Brainsway Gets Approval for U.S., Canada Licensing After Test

Brainsway Ltd. (BRIN) released the final results of a multichannel stimulator test and received an approval needed to license the stimulator in the U.S. and Canada, the maker of devices to treat neurological disorders said today in a filing to the Tel Aviv Stock Exchange.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Calev Ben-David at cbendavid@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.